Synopsis
Synopsis
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cystorelin
2. Dirigestran
3. Factrel
4. Fsh Releasing Hormone
5. Fsh-releasing Hormone
6. Gn-rh
7. Gnrh
8. Gonadoliberin
9. Gonadorelin
10. Gonadorelin Hydrochloride
11. Gonadotropin Releasing Hormone
12. Gonadotropin-releasing Hormone
13. Kryptocur
14. Lfrh
15. Lh Fsh Releasing Hormone
16. Lh Releasing Hormone
17. Lh-fsh Releasing Hormone
18. Lh-releasing Hormone
19. Lh-rh
20. Lhfsh Releasing Hormone
21. Lhfshrh
22. Lhrh
23. Luliberin
24. Luteinizing Hormone Releasing Hormone
25. Luteinizing Hormone-releasing Hormone
26. Releasing Hormone, Lhfsh
1. 34973-08-5
2. Gonadorelin (acetate)
3. Luteinizing Hormone-releasing Factor (swine), Acetate (salt)
4. 34973-08-5 (acetate)
5. Luprolite Acetate
6. Fertagyl
7. Hypocrine
8. Cystorelin
9. Fertiline
10. Lutrelef
11. Lutrepulse
12. Gonadorelin Diacetate
13. 33515-09-2
14. 71447-49-9
15. Gnrh
16. Gonadorelin Acetate Anhydrous
17. Unii-k56qt79s2o
18. Luteinizing
19. Luteinizing Hormone-releasing Factor (pig), Acetate (salt)
20. Gnrh-i Acetate
21. Abbott-41070
22. Synthetic Luteinizing Hormone-releasing Factor Acetate
23. Lhrh Acetate
24. Gonadorelin Acetate Mixture
25. Unii-z6tk4t303l
26. K56qt79s2o
27. Z6tk4t303l
28. Chembl1200511
29. Dtxsid30198161
30. Mfcd01742354
31. Cs-5289
32. Hy-12555
33. 47g499
34. Luteinizing Hormone Releasing Factor Monoacetate
35. Luteinizing Hormone-releasing Factor Diacetate Tetrahydrate
Molecular Weight | 1242.3 g/mol |
---|---|
Molecular Formula | C57H79N17O15 |
Hydrogen Bond Donor Count | 17 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 31 |
Exact Mass | 1241.59415488 g/mol |
Monoisotopic Mass | 1241.59415488 g/mol |
Topological Polar Surface Area | 512 Ų |
Heavy Atom Count | 89 |
Formal Charge | 0 |
Complexity | 2420 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
10
PharmaCompass offers a list of Gonadorelin Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gonadorelin Acetate manufacturer or Gonadorelin Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gonadorelin Acetate manufacturer or Gonadorelin Acetate supplier.
PharmaCompass also assists you with knowing the Gonadorelin Acetate API Price utilized in the formulation of products. Gonadorelin Acetate API Price is not always fixed or binding as the Gonadorelin Acetate Price is obtained through a variety of data sources. The Gonadorelin Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fertiline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fertiline, including repackagers and relabelers. The FDA regulates Fertiline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fertiline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fertiline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fertiline supplier is an individual or a company that provides Fertiline active pharmaceutical ingredient (API) or Fertiline finished formulations upon request. The Fertiline suppliers may include Fertiline API manufacturers, exporters, distributors and traders.
click here to find a list of Fertiline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fertiline DMF (Drug Master File) is a document detailing the whole manufacturing process of Fertiline active pharmaceutical ingredient (API) in detail. Different forms of Fertiline DMFs exist exist since differing nations have different regulations, such as Fertiline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fertiline DMF submitted to regulatory agencies in the US is known as a USDMF. Fertiline USDMF includes data on Fertiline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fertiline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fertiline suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fertiline Drug Master File in Japan (Fertiline JDMF) empowers Fertiline API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fertiline JDMF during the approval evaluation for pharmaceutical products. At the time of Fertiline JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fertiline suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fertiline Drug Master File in Korea (Fertiline KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fertiline. The MFDS reviews the Fertiline KDMF as part of the drug registration process and uses the information provided in the Fertiline KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fertiline KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fertiline API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fertiline suppliers with KDMF on PharmaCompass.
A Fertiline CEP of the European Pharmacopoeia monograph is often referred to as a Fertiline Certificate of Suitability (COS). The purpose of a Fertiline CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fertiline EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fertiline to their clients by showing that a Fertiline CEP has been issued for it. The manufacturer submits a Fertiline CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fertiline CEP holder for the record. Additionally, the data presented in the Fertiline CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fertiline DMF.
A Fertiline CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fertiline CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fertiline suppliers with CEP (COS) on PharmaCompass.
A Fertiline written confirmation (Fertiline WC) is an official document issued by a regulatory agency to a Fertiline manufacturer, verifying that the manufacturing facility of a Fertiline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fertiline APIs or Fertiline finished pharmaceutical products to another nation, regulatory agencies frequently require a Fertiline WC (written confirmation) as part of the regulatory process.
click here to find a list of Fertiline suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fertiline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fertiline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fertiline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fertiline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fertiline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fertiline suppliers with NDC on PharmaCompass.
Fertiline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fertiline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fertiline GMP manufacturer or Fertiline GMP API supplier for your needs.
A Fertiline CoA (Certificate of Analysis) is a formal document that attests to Fertiline's compliance with Fertiline specifications and serves as a tool for batch-level quality control.
Fertiline CoA mostly includes findings from lab analyses of a specific batch. For each Fertiline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fertiline may be tested according to a variety of international standards, such as European Pharmacopoeia (Fertiline EP), Fertiline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fertiline USP).